NCT03979365View on ClinicalTrials.gov

Envarsus XR Compared to Immediate Release Tacrolimus

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Kidney Transplant Recipients
Interventions
DRUG

Envarsus XR

Twice daily tacrolimus vs. Envarsus XR

DRUG

Tacrolimus twice daily

Twice daily tacrolimus vs. Envarsus XR

Trial Locations (3)

32224

Mayo Clinic Florida, Jacksonville

55905

Mayo Clinic Rochester, Rochester

85054

Mayo Clinic Arizona, Phoenix

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Veloxis Pharmaceuticals
All Listed Sponsors
collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

Mayo Clinic

OTHER